1688-0420

S1688-04202019000300305

10.29277/cardio.34.3.24

Argentina

00 12 2019

34 3 305 332

2001 5 4 4

378-87

2003 24 3 3

225-48

2007 297 12 12

1344-53

2004 291 9 9

1071-80

2008 117 19 19

2458-66

2011 365 22 22

2078-87

2015 36 8 8

490-500

1996 335 14 14

1001-9

Scandinavian Simvastatin Survival Study Group

1994 344 8934 8934

1383-9

Heart Protection Study Collaborative Group

2002 360 9326 9326

7-22

Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group

1998 339 19 19

1349-57

2002 360 9346 9346

1623-30

2004 350 15 15

1495-504

2004 292 11 11

1307-16

2005 352 14 14

1425-35

2005 294 19 19

2437-45

2006 48 3 3

438-45

Cholesterol Treatment Trialists’ (CTT) Collaboration

2010 376 9753 9753

1670-81

2018 137 19 19

1997-2009

2006 355 6 6

549-59

2017 6 7 7

2014 63 25 25

2889-934

2017 38 32 32

2459-72

2009 373 9670 9670

1175-82

2014 64 5 5

485-94

2015 372 25 25

2387-97

2017 376 18 18

1713-22

2017 390 10106 10106

1962-71

2018 379 22 22

2097-107

2016 37 39 39

2999-3058

2018 7 21 21

2019 73 24 24

3168-209

Sociedad Argentina de Cardiología. Área de Consensos y Normas

2018 86 ^s1 ^s1 1

1-13

1995 333 20 20

1301-7

1998 279 20 20

1615-22

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group

2002 288 23 23

2998-3007

2003 361 9364 9364

1149-58

2006 368 9542 9542

1155-63

2016 374 21 21

2021-31

2008 359 21 21

2195-207

2017 136 20 20

1878-91

2016 37 29 29

2315-81

2004 364 9435 9435

685-96

Cholesterol Treatment Trialists’ (CTT) Collaborators

2008 371 9607 9607

117-25

2011 377 9784 9784

2181-92

2014 5 5

2005 353 3 3

238-48

2009 360 14 14

1395-407

2010 55 15 15

1600-7

2008 358 13 13

1336-45

2005 46 1 1

166-72

2018 72 25 25

3233-42

2017 69 22 22

2696-706

2018 71 16 16

1729-37

2008 29 24 24

3052-60

2005 83 11 11

820-9

2013 20 4 4

678-85

2011 378 9798 9798

1231-43

2019 26 8 8

824-35

2019 79

104-10

2018 122 5 5

756-61

2016 67 11 11

1278-85